Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: a multicenter survey.

Cook D, Duffett M, Lauzier F, Ye C, Dodek P, Paunovic B, Fowler R, Kho ME, Foster D, Stelfox T, Sinuff T, Zytaruk N, Clarke F, Wood G, Cox M, Kutsiogiannis J, Jacka M, Roussos M, Kumar H, Guyatt G; CONECCKT-T (Co-operative Network of Critical Care Knowledge Translation for Thromboprophylaxis) Investigators; Canadian Critical Care Trials Group.

J Crit Care. 2014 Jun;29(3):471.e1-9. doi: 10.1016/j.jcrc.2014.01.017. Epub 2014 Feb 5.

PMID:
24629574
2.

Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study.

Cook DJ, Rocker G, Meade M, Guyatt G, Geerts W, Anderson D, Skrobik Y, Hebert P, Albert M, Cooper J, Bates S, Caco C, Finfer S, Fowler R, Freitag A, Granton J, Jones G, Langevin S, Mehta S, Pagliarello G, Poirier G, Rabbat C, Schiff D, Griffith L, Crowther M; PROTECT Investigators; Canadian Critical Care Trials Group.

J Crit Care. 2005 Dec;20(4):364-72.

PMID:
16310609
3.

Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review.

Ribic C, Lim W, Cook D, Crowther M.

J Crit Care. 2009 Jun;24(2):197-205. doi: 10.1016/j.jcrc.2008.11.002. Epub 2009 Feb 7. Review.

PMID:
19327323
4.

Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit.

Lauzier F, Muscedere J, Deland E, Kutsogiannis DJ, Jacka M, Heels-Ansdell D, Crowther M, Cartin-Ceba R, Cox MJ, Zytaruk N, Foster D, Sinuff T, Clarke F, Thompson P, Hanna S, Cook D; Co-operative Network of Critical Care Knowledge Translation for Thromboprophylaxis (CONECCKT-T) Investigators; Canadian Critical Care Trials Group.

Crit Care. 2014 Apr 25;18(2):R82. doi: 10.1186/cc13844.

5.

Thromboprophylaxis for intensive care patients in Australia and New Zealand: a brief survey report.

Cooper DJ, Bishop N, Cade J, Finfer S, Gallus A, Myburgh J; Australian and New Zealand Intensive Care Society Clinical Trials Group.

J Crit Care. 2005 Dec;20(4):354-6.

PMID:
16310607
6.

[Thrombosis prophylaxis with heparins in intensive care patients].

Greinacher A, Janssen D.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2005 Mar;40(3):156-63. Review. German.

PMID:
15770559
7.

Thromboprophylaxis in medically ill patients at risk for venous thromboembolism.

Burleigh E, Wang C, Foster D, Heller S, Dunn D, Safavi K, Griffin B, Smith J.

Am J Health Syst Pharm. 2006 Oct 15;63(20 Suppl 6):S23-9.

PMID:
17032931
8.

Survey of pharmacologic thromboprophylaxis in critically ill children.

Faustino EV, Patel S, Thiagarajan RR, Cook DJ, Northrup V, Randolph AG.

Crit Care Med. 2011 Jul;39(7):1773-8. doi: 10.1097/CCM.0b013e3182186ec0.

9.

Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.

Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ.

Crit Care Med. 2013 Sep;41(9):2088-98. doi: 10.1097/CCM.0b013e31828cf104. Review.

PMID:
23782973
10.

Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency.

Rabbat CG, Cook DJ, Crowther MA, McDonald E, Clarke F, Meade MO, Lee KA, Cook RJ.

J Crit Care. 2005 Dec;20(4):357-63.

PMID:
16310608
11.

Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey.

Cook D, McMullin J, Hodder R, Heule M, Pinilla J, Dodek P, Stewart T; Canadian ICU Directors Group.

Crit Care. 2001 Dec;5(6):336-42. Epub 2001 Sep 26.

12.

Enoxaparin for thromboprophylaxis after major trauma: potential cost implications.

Shorr AF, Ramage AS.

Crit Care Med. 2001 Sep;29(9):1659-65.

PMID:
11546959
13.

Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.

Hull RD, Raskob GE, Pineo GF, Feldstein W, Rosenbloom D, Gafni A, Green D, Feinglass J, Trowbridge AA, Elliott CG.

Arch Intern Med. 1997 Feb 10;157(3):298-303.

PMID:
9040296
14.

Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients.

Cook DJ, Crowther MA.

Crit Care Med. 2010 Feb;38(2 Suppl):S76-82. doi: 10.1097/CCM.0b013e3181c9e344. Review.

PMID:
20083918
15.

Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.

Adam SS, McDuffie JR, Lachiewicz PF, Ortel TL, Williams JW Jr.

Ann Intern Med. 2013 Aug 20;159(4):275-84. doi: 10.7326/0003-4819-159-4-201308200-00008. Review.

16.

Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): a multicenter, observational, cross-sectional study.

Parikh KC, Oh D, Sittipunt C, Kalim H, Ullah S, Aggarwal SK; VOICE Asia Investigators.

Thromb Res. 2012 Apr;129(4):e152-8. doi: 10.1016/j.thromres.2012.01.012. Epub 2012 Feb 11.

PMID:
22326367
17.

Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis.

Shorr AF, Jackson WL, Weiss BM, Moores LK.

Blood Coagul Fibrinolysis. 2007 Jun;18(4):309-16.

PMID:
17473570
18.

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.

Donath L, Lützner J, Werth S, Kuhlisch E, Hartmann A, Günther KP, Weiss N, Beyer-Westendorf J.

Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x.

19.

Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study.

McMullin J, Cook D, Griffith L, McDonald E, Clarke F, Guyatt G, Gibson J, Crowther M.

Crit Care Med. 2006 Mar;34(3):694-9.

PMID:
16505655
20.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
Items per page

Supplemental Content

Write to the Help Desk